Surgical-Clinical Correlation in Unilateral Conductive Hearing Loss With Intact Tympanic Membrane
1 other identifier
interventional
100
1 country
1
Brief Summary
Unilateral conductive hearing loss (UCHL) in the presence of an intact tympanic membrane represents a diagnostic challenge in otologic practice. In the absence of middle ear effusion or tympanic membrane pathology, stapes fixation secondary to otosclerosis is often considered the most probable diagnosis. However, although otosclerosis is traditionally regarded as a bilateral disease, clinical presentation may be unilateral due to asymmetric disease progression or subclinical contralateral involvement. Other etiologies, including congenital ossicular anomalies, ossicular discontinuity, tympanosclerosis without tympanic membrane involvement, or oval window abnormalities, may mimic otosclerosis both clinically and audiologically. Consequently, exploratory tympanotomy remains the gold standard for definitive diagnosis, allowing direct assessment of ossicular chain mobility and confirmation of stapes fixation. Correlating preoperative clinical suspicion with intraoperative findings is therefore essential to better define the true causes of unilateral conductive hearing loss with an intact tympanic membrane.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
February 19, 2026
CompletedFirst Posted
Study publicly available on registry
February 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
CompletedJuly 24, 2026
January 1, 2026
7 months
February 19, 2026
July 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement of the Airborne ( conductive ) gap
Difference between preoperative and postoperative Average Airbone gap in dicebel
up to three months Surgery
Study Arms (1)
Patients presented with unilatral conductive hearing loss with intact tympanic memebrane
OTHERPatients who presented with unilateral conductive hearing loss with intact tympanic membrane will undergo exploration tympanoplasty to diagnose underlying causes and correct them surgically if possible
Interventions
exploration tympanotomy of the middle ear and ossicles to diagnose or detect actual causes of conductive hearing loss and correct it according to the cause
Eligibility Criteria
You may qualify if:
- unilateral conductive hearing loss or mixed HL with intact Tympanic Membrane
You may not qualify if:
- Sensorineural hearing loss
- Chronic otitis media
- TM perforation
- Previous ear surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alazhar university Hopital in Assiut
Asyut, Asyut Governorate, 17511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident doctor of otorhinolarngolgoy
Study Record Dates
First Submitted
February 19, 2026
First Posted
February 24, 2026
Study Start
January 1, 2026
Primary Completion
August 1, 2026
Study Completion
August 1, 2026
Last Updated
July 24, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to institutional ethical restrictions and the retrospective nature of the study. The dataset contains potentially identifiable clinical and surgical information. De-identified aggregated data may be made available upon reasonable request to the corresponding author, subject to institutional review and approval.